Analysts See $-0.01 EPS for STAAR Surgical Company (STAA) on May, 2

April 20, 2018 - By Tracy Fowler

STAAR Surgical Company (NASDAQ:STAA) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 1.79. That’s change of 0.07, from 2017Q3’s 1.86. 6 investors sold all, 23 reduced holdings as STAAR Surgical Company ratio fall. 32 grew positions while 20 funds acquired positions. Funds hold 31.89 million shares thus 0.95% more from 2017Q3’s 31.59 million shares.
New York-based Ny State Common Retirement Fund has invested 0% in STAAR Surgical Company (NASDAQ:STAA). Great West Life Assurance Can has invested 0% in STAAR Surgical Company (NASDAQ:STAA). Renaissance Techs Ltd Limited Liability Company holds 318,400 shs or 0.01% of its capital. Rice Hall James And Associate Ltd Liability Com holds 0.1% or 157,759 shs. Driehaus Capital Mgmt Limited Com holds 18,863 shs or 0.01% of its capital. Millrace Asset has invested 1.54% in STAAR Surgical Company (NASDAQ:STAA). Legal General Gru Public Limited Co accumulated 9,817 shs or 0% of the stock. California Employees Retirement Sys, a California-based fund reported 51,759 shs. Grandeur Peak Glob Advisors Ltd has invested 0.66% in STAAR Surgical Company (NASDAQ:STAA). Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% stake. Quantum Cap reported 57,195 shs. Bollard Llc has invested 0.01% in STAAR Surgical Company (NASDAQ:STAA). Jpmorgan Chase Company has 0% invested in STAAR Surgical Company (NASDAQ:STAA). State Board Of Administration Of Florida Retirement reported 0% of its capital in STAAR Surgical Company (NASDAQ:STAA). California State Teachers Retirement Sys, California-based fund reported 64,470 shs.

STAAR Surgical Company had 5 sales and 0 insider buys since March 19, 2018. This’s net activity of $216,553. Mason Caren L sold $107,272 worth of STAAR Surgical Company (NASDAQ:STAA) or 6,667 shs on Monday, March 19. On Thursday, March 22 Shares for $35,065 were sold by Holliday Keith. On Thursday, March 22 Gesten Samuel J sold $45,470 worth of STAAR Surgical Company (NASDAQ:STAA).

On May, 2 STAAR Surgical Company (NASDAQ:STAA)’s earnings release is anticipated by WallStreet, as reported by Faxor. Analysts have anticipation on stock’s earnings per share of $-0.01. That’s up 80.00 % from last year’s $-0.05 earnings per share. Analysts at Wall Street see STAAR Surgical Company’s -150.00 % negative EPS growth compared to $0.02 earnings per share for last quarter. Ticker’s shares touched $15.5 during the last trading session after 0.64% change.STAAR Surgical Company has volume of 61,565 shares. Since April 20, 2017 STAA has risen 52.85% and is uptrending. STAA outperformed by 41.30% the S&P500.

STAAR Surgical Company (NASDAQ:STAA) Ratings Coverage

Total analysts of 3 have positions in Staar Surgical Company (NASDAQ:STAA) as follows: 2 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 67%. The firm has $21.0 highest while $13.0 is the lowest Target. The average target $18 is 16.13% above the last ($15.5) price. Since November 8, 2017 according to StockzIntelligence Inc Staar Surgical Company has 4 analyst reports. On Friday, November 17 the stock of STAAR Surgical Company (NASDAQ:STAA) earned “Buy” rating by Canaccord Genuity. In Monday, November 20 report Benchmark maintained it with “Buy” rating and $21.0 target. On Thursday, March 1 the stock of STAAR Surgical Company (NASDAQ:STAA) earned “Hold” rating by Stephens. On Wednesday, November 8 Canaccord Genuity maintained STAAR Surgical Company (NASDAQ:STAA) with “Buy” rating.

STAAR Surgical Company, together with its subsidiaries, designs, develops, makes, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.The firm is valued at $641.98 million. The firm provides Visian implantable collamer lenses to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.Currently it has negative earnings. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.

STAAR Surgical Company (NASDAQ:STAA) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.